Patents Assigned to HANLIM PHARMACETICAL CO., LTD.
  • PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF OSTEOARTHRITIS CONTAINING REBAMIPIDE AS AN ACTIVE INGREDIENT
    Publication number: 20130065920
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating osteoarthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Application
    Filed: March 4, 2011
    Publication date: March 14, 2013
    Applicant: HANLIM PHARMACETICAL CO., LTD.
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Young-Ok Jung, Geun-Hyeog Lee, Byong-Sun Choi, Jin-Ha Park, Eun-Young Kwak